Yong-Kwei Tsau Selected Research

Yong-Kwei Tsau Research Topics

Disease

6	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2019 - 01/2006
6	Fever (Fevers) 07/2010 - 01/2006
4	Infections 09/2011 - 10/2006
4	Pyelonephritis 01/2011 - 03/2007
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2021
3	Proteinuria 09/2019 - 09/2012
3	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 04/2011 - 04/2005
2	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2014 - 01/2007
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2013 - 11/2003
2	Cicatrix (Scar) 12/2011 - 07/2010
2	Bacterial Infections (Bacterial Infection) 08/2010 - 07/2010
2	Escherichia coli Infections 08/2010 - 12/2008
2	Urinary Tract Infections (Urinary Tract Infection) 12/2008 - 03/2007
2	Hypertrophy 04/2006 - 07/2002
2	Biliary Atresia 11/2005 - 07/2002
1	COVID-19 11/2023
1	Critical Illness (Critically Ill) 09/2021
1	Chronic Renal Insufficiency 01/2021
1	Fanconi Syndrome (Syndrome, Fanconi) 12/2015
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 12/2015
1	Inborn Urea Cycle Disorders 01/2014
1	Maple Syrup Urine Disease 01/2014
1	Methylmalonic acidemia 01/2014
1	Lipoprotein Glomerulopathy 09/2012
1	Hypertension (High Blood Pressure) 04/2011
1	Cystitis 08/2010
1	Disease Progression 06/2010
1	Abscess 01/2010
1	Hyperphosphatemia 10/2008
1	Hypocalcemia 10/2008
1	Thrombocytopenia (Thrombopenia) 10/2006
1	Renal Insufficiency (Renal Failure) 10/2006
1	Body Weight (Weight, Body) 04/2006
1	Hepatoblastoma 11/2005
1	Urinoma 04/2005
1	Acidosis 04/2005
1	Polydipsia 01/2005
1	Water Intoxication 01/2005
1	Thrombosis (Thrombus) 11/2003

Drug/Important Bio-Agent (IBA)

7	Anti-Bacterial Agents (Antibiotics)IBA 01/2011 - 01/2006
3	CreatinineIBA 01/2021 - 07/2002
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2006 - 07/2002
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2006 - 07/2002
2	Technetium (Technetium 99m)IBA 12/2011 - 03/2007
2	Virulence Factors (Pathogenicity Factors)IBA 08/2010 - 03/2007
2	C-Reactive ProteinIBA 06/2010 - 03/2007
2	SteroidsIBA 04/2010 - 01/2006
1	VaccinesIBA 11/2023
1	Complement C5a (Complement 5a)IBA 09/2019
1	Deferasirox FDA Link 12/2015
1	Complement System Proteins (Complement)IBA 08/2015
1	rho-Associated KinasesIBA 08/2015
1	Methylmalonic AcidIBA 01/2014
1	AmmoniaIBA 01/2014
1	Leucine (L-Leucine)FDA Link 01/2014
1	apolipoprotein E2 (Kyoto)IBA 09/2012
1	LipidsIBA 09/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2012
1	Succinic Acid (Succinate)IBA 12/2011
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2011
1	BilirubinIBA 04/2011
1	Interleukin-8 (Interleukin 8)IBA 04/2011
1	Succimer (Dimercaptosuccinic Acid)FDA Link 07/2010
1	Chlorambucil (Leukeran)FDA Link 04/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2010
1	beta-Lactamases (beta-Lactamase)IBA 12/2008
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 12/2008
1	Cephalosporins (Cephalosporin Antibiotics)IBA 12/2008
1	Parathyroid Hormone (Parathormone)IBA 10/2008
1	AcidsIBA 03/2007
1	Linezolid (Zyvox)FDA Link 10/2006
1	DNA (Deoxyribonucleic Acid)IBA 04/2006
1	Proteins (Proteins, Gene)FDA Link 04/2006
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2006
1	Phosphates (Orthophosphate)IBA 04/2005
1	BuffersIBA 04/2005
1	Drinking WaterIBA 01/2005

Therapy/Procedure

4	Aftercare (After-Treatment) 12/2011 - 04/2009
4	Therapeutics 04/2009 - 01/2006
2	Extracorporeal Membrane Oxygenation 01/2022 - 09/2021
2	Kidney Transplantation 04/2013 - 11/2003
1	Renal Dialysis (Hemodialysis) 01/2014
1	Operative Surgical Procedures 04/2013
1	Duration of Therapy 07/2010
1	Length of Stay 06/2010
1	Antibiotic Prophylaxis 12/2008
1	Continuous Renal Replacement Therapy 01/2007
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2007
1	Nephrectomy 04/2006
1	Ligation 04/2006
1	Liver Transplantation 11/2005
1	Transplantation 11/2003